Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Nuvation Bio

Youtube Subscribe

...

Ticker: NUVB

Sector: Biotechnology

Nuvation Bio Inc. focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a selective oral small molecule BET inhibitor. NUV:868 is an oral small.
...
...
Extended Summary

Nuvation Bio

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform that focuses on targeting an inhibitor of poly ADP ribose polymerase (PARP) to anti-cancer warheads of existing drugs, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. Nuvation Bio Inc. was founded in 2018 and is headquartered in New York, New York.

Related Results

...
February 18, 2024 18:14 (London Time)

Nuvation Bio

Nuvation Bio Inc. (NUVB) is a biopharmaceutical company tackling some of the greatest unmetcology needs by developing novel therapeutic candidates. …
Sector: Biotechnology
Ticker: NUVB
Sentiment: 0.7579
MarketCap: 378,773,211.0
High: 1.81 Low: 1.71

Open: 1.78 Close: 1.73 Change: -0.05

Read more →
...
June 28, 2023 17:50 (London Time)

Nuvation Bio

Nuvation Bio Inc. is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therap…
Sector: Biotechnology
Ticker: NUVB
Sentiment: 0.7579
MarketCap: 384,656,513.0
High: 1.78 Low: 1.72

Open: 1.75 Close: 1.75 Change: 0.0

Read more →
...
September 17, 2023 5:17 (London Time)

Nuvation Bio

Nuvation Bio Inc. reported a net loss of $20.6 million, or $0.09 per share in the second quarter of 2023. Nuvation Bio (NYSE: NUVB ) shares were dow…
Sector: Biotechnology
Ticker: NUVB
Sentiment: 0.0
MarketCap: 284,569,300.0
High: 1.41 Low: 1.3

Open: 1.38 Close: 1.3 Change: -0.08

Read more →
Search
Happening Now
Categories